Azenta, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 513.70M | 555.50M | 665.07M | 573.45M | 593.82M | 3.6% | |
| Cost of Revenue | (299.19M) | (324.88M) | (431.82M) | (318.83M) | (323.54M) | 1.5% | |
Gross Profit | 214.51M | 230.62M | 233.26M | 254.62M | 270.28M | 6.1% | |
| Operating Expenses | |||||||
| Research & Development | (22.41M) | (27.54M) | (33.96M) | (31.52M) | (30.39M) | -3.6% | |
| Selling, General & Administrative | (188.50M) | (227.10M) | (281.50M) | (253.08M) | (251.16M) | -0.8% | |
| Depreciation & Amortization | (56.87M) | (53.70M) | (85.58M) | (90.74M) | (61.21M) | -32.5% | |
Operating Income (EBIT) | 3.60M | -24.02M | -82.20M | -29.98M | -11.27M | -62.4% | |
| Non-Operating Items | |||||||
| Interest Income | 632.00K | 20.29M | 43.73M | 33.18M | 18.78M | -43.4% | |
| Interest Expense | (2.04M) | (4.59M) | — | — | — | — | |
| Other Income/Expenses (Net) | -52.56M | 14.09M | 51.77M | 10.86M | 4.13M | -62.0% | |
Income Before Tax | -48.97M | -9.94M | -30.43M | -19.13M | -7.14M | -62.7% | |
| Income Tax Expense | (20.10M) | (1.35M) | (17.55M) | (5.24M) | (31.60M) | -703.0% | |
Net Income | 110.75M | -428.96M | -14.26M | -164.90M | -55.76M | -66.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-0 | $-0 | $-0 | $-3 | $-1 | -60.5% | |
| Weighted Avg Shares Outstanding | 74.23M | 74.90M | 66.25M | 53.17M | 45.74M | -14.0% | |
| Weighted Avg Shares Outstanding (Diluted) | 74.45M | 74.90M | 66.25M | 53.17M | 45.90M | -13.7% | |
EBITDA | 9.94M | 48.35M | 55.15M | 71.62M | 54.07M | -24.5% |
Explore AZTA
AZTA in the Healthcare
Small Cap